The function of G protein-coupled receptors (GPCRs) can be modulated by a number of endogenous allosteric molecules. In this study, we used molecular dynamics, radioligand binding and thermostability experiments to elucidate the role of the recently discovered sodium ion binding site in the allosteric modulation of the human A 2A adenosine receptor, conserved among class A GPCRs. While the binding of antagonists and sodium ions to the receptor was noncompetitive in nature, the binding of agonists and sodium ions appears to require mutually exclusive conformational states of the receptor. Amiloride analogs can also bind to the sodium binding pocket, showing distinct patterns of agonist and antagonist modulation. These findings suggest that physiological concentrations of sodium ions affect functionally relevant conformational states of GPCRs, and can help to design novel synthetic allosteric modulators or bitopic ligands exploiting the sodium ion binding pocket.
Introduction
Cellular responses to a wide variety of extracellular signals are mediated by the superfamily of seven transmembrane helical receptors coupled to intracellular G proteins (G protein-coupled receptors, GPCRs). It is now well recognized that many GPCRs function as "allosteric machines" with the orthosteric binding pocket representing just one of the many sites for possible signal modulation and pharmacological intervention. Thus, molecules targeting other (allosteric) sites can modulate binding of native orthosteric ligands and shift the delicate equilibrium between active and inactive states of GPCRs. 1 Potential therapeutic advantages include a gain in target selectivity, the "ceiling effect", and preservation of the spatiotemporal profile of intercellular signaling. [2] [3] [4] [5] Some endogenous chemical entities, such as ions or lipids, have also been demonstrated to act as allosteric modulators of GPCRs, 1, 6, 7 but the structural basis and functional importance of these interactions are not well understood.
Recent advances in protein engineering and membrane protein crystallography [8] [9] [10] have led to the elucidation of a growing number of experimental GPCR structures, 11 contributing to the alluring perspective of structure-based drug design, 12 and the deciphering of molecular mechanisms underlying conformational equilibrium. 13 Several receptors, including one of the best-characterized GPCRs, the A 2A adenosine receptor (A 2A AR), have been crystallized in inactive [14] [15] [16] [17] and active-like 18, 19 conformations. The conformational changes associated with A 2A AR activation mirrored similar structural changes observed in other receptors, namely the β 2 -adrenergic receptor ( 2 AR) 20 and rhodopsin. 21 Recently, the 1.8 Å resolution structure of inactive A 2A AR in complex with ZM-241,385 revealed the presence of a sodium ion bound to the core of the transmembrane (TM) bundle, 22 coordinated by Asp 2.50 and other side chains highly conserved in class A GPCRs 23 and by a cluster of structural water molecules. 24, 25 The allosteric effect of sodium ions has been described previously in A 2A and A 1 adenosine receptors, 6, 26 as well as in GPCRs from other subfamilies such as dopamine D 2 , 7, 27 opioid, 28, 29 or -adrenergic receptors, 30, 31 among others. Similarly, the positively charged, synthetic small molecule amiloride and its analogs have been found to be allosteric modulators of agonist and antagonist binding of a number of GPCRs (Chapter 2), including A 2A AR, and were shown to compete with sodium ions for the same binding site. 6 Moreover, mutation of Asp 2.50 to either asparagine or alanine has been shown to reduce or abrogate the allosteric effects of sodium ions or amiloride in many GPCRs. 7, [32] [33] [34] While the 1.8 Å structure of A 2A AR provides a static picture of sodium interactions with the receptor, the dynamic nature of the sodium ion-water cluster, its effect on binding of orthosteric agonists and antagonists, and its functional role are poorly understood. Molecular dynamics (MD) studies, supported by biochemical and biophysical experiments, provide a molecular framework for the allosteric effects of sodium and amilorides, which can ultimately aid in the discovery of new compounds targeting this site. 4 
Material and methods

Computational simulations
The standard amino acid sequence numbering for the human A 2A AR is used in the text, with the Ballesteros and Weinstein residue numbering for GPCRs 35 shown in superscript if the residue belongs to a transmembrane helix. The inactive structure of the A 2A AR in complex with ZM-241,385 and a sodium ion (PDB code 4EIY), 22 was refined in order to model the missing loops and add protons as detailed in the supplemental information, prior to MD simulations. When the sodium ion was not considered, manual replacement with a water molecule, also maintaining the surrounding water molecules, was followed by energy minimization to fully optimize the H-bond network in the allosteric site. In the simulations with amiloride, the initial conformation of the A 2A AR-amiloride complex was used as proposed previously by flexible docking. 22 The starting coordinates of the antagonist caffeine were obtained by superimposing the A 2A AR-caffeine complex (PDB code 3RFM) 14 with the A 2A AR structure described above using PyMOL (The PyMOL Molecular Graphics System version 1.4, Schrödinger). The MD simulations of the activelike conformation were performed starting from the A 2A AR in complex with the stabilizing agonist UK-432,097 (PDB code 3QAK). 19 The starting coordinates of the sodium ion and coordinating water molecules were transposed from the inactive structure by structural superimposition with 4EIY. Finally, the A 2A AR in complex with the agonist NECA was obtained by "morphing" the A 2A AR-ZM-241,385 structure (PDB code 4EIY) to the activestate A 2A AR-UK-432,097 conformation (PDB code 3QAK), and subsequent reconstruction of the intracellular loop 3 as detailed in the supplemental experimental procedures. Note that the available crystal structure of NECA in complex with thermostabilized A 2A AR (PDB code 2YDV), 18 was not suitable for this analysis because of a highly distorted conformation of the allosteric site, which includes a deformed helix VII backbone due to a cis-Proline in the NPxxY motif. Membrane insertion and all MD simulations were performed with the GROMACS software, 36 using our original protocol for the MD simulations of GPCRs 37 as adapted in the PyMemDyn program. 38 The final systems, consisting of approximately 50,000 atoms (~74% belong to solvent molecules, ~15% to lipids and ~11% to protein and ligand atoms), were energy minimized and equilibrated for a total of 5 ns, with specific details provided in the supplemental experimental procedures. The production phase of unrestrained MD simulations followed for 100 ns simulation time (shorter production times were considered in certain cases, see Table 1 and explanation in main text). MD simulations were performed under the OPLSAA force field, 39 with ligand parameters obtained with Macromodel, 40 lipid parameters adapted from Berger 41 together with the use of the half- double-pairlist method 42 and the SPC water model. 43 The periodic boundary conditions (PBC) were implemented with hexagonal prism-shaped boxes in the isobaric NPT ensemble, using a Nose-Hoover thermostat 44 with a target temperature of 310 K using.
Electrostatic interactions beyond a cutoff of 12 Å were estimated with the particle mesh Ewald (PME) method. All MD analyses were conducted with several GROMACS and VMD 45 utilities. Molecular superimpositions, trajectory visualizations and molecular images were performed with PyMOL.
Cell growth and transfection
HEK293T cells were grown in culture medium consisting of Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% newborn calf serum (NCS), 50 µg/ml streptomycin and 50 IU/ml penicillin at 37 °C and 7% CO 2 . Cells were subcultured twice a
week at a ratio of 1:15 on 10 cm ø plates. Cells were transfected with the wild-type A 2A ARplasmid (pcDNA3.1, 1 µg) using the calcium phosphate precipitation method. 46
Membrane preparation
Cells were detached from plates 48 h after transfection by scraping them into 5 ml phosphate buffered saline (PBS), collected and centrifuged at 700 ×g (3000 rpm) for 5 min.
Pellets derived from 50 plates (10 cm ø) were pooled and resuspended in 40 ml of ice-cold assay buffer (50 mM Tris-HCl supplemented with 5 mM MgCl 2 , pH 7.4). An Ultra-Turrax was used to homogenize the cell suspension. Membranes and the cytosolic fraction were separated by centrifugation at 100,000 ×g (31,000 rpm) in a Beckman Optima LE-80K ultracentrifuge at 4 °C for 20 min. The pellet was resuspended in 20 ml of Tris buffer and the homogenization and centrifugation step was repeated. Assay buffer (10 ml) was used to resuspend the pellet and adenosine deaminase (ADA) was added (0.8 IU/ml) to break down endogenous adenosine. Membranes were stored in 250 µl aliquots at -80 °C.
Membrane protein concentrations were measured using the BCA (bicinchoninic acid) method. 47
Competition and saturation binding assays using HEK293T cell membranes
For 
Thermostability assays
The A 2A AR-BRIL-ΔC receptor construct was purified from Spodoptera frugiperda (Sf9) insect cells in the apo form as described previously, 22 
Data analysis
The radioligand binding and thermostability data were processed with Prism 5 (GraphPad Software, San Diego, CA, USA). Statistical significance was assessed with a Student's t-test.
Results
Molecular dynamics studies
A series of MD simulations were designed to evaluate the functional role of the sodium ion in the A 2A AR, as summarized in Table 1 . 
The sodium binding site in the A 2A AR inactive conformation
In the high resolution crystal structure of inactive A 2A AR, 22 the sodium ion is directly coordinated by Asp52 2.50 and Ser91 3.39 (first shell residues) and three structured water molecules ( Figure 1A ). Water molecules also bridge interactions with residues in the second (Trp246 6.48 and Asn280 7.45 ), and the third shells ( Table 1 ). The starting crystal structure is displayed, together with the electron density (contoured at 1  level, black). B) The time-evolution of the distances between the sodium ion and Asp 2.50 (blue), Ser 3.39 (red) and Asn 7.45 (green), shown for the 3 independent replicates (R1-R3) of MDS1. The corresponding distances are denoted as dashed lines in A with the same color code, and are the source of the data in Table S1 . The RMSD of the ion with respect to its crystallographic position is indicated with a black line, while the horizontal bar at 1.8 Å (the resolution of the parent crystal structure) denotes the limit for the crystallographic coordination state (position c1). See also Table S1 and Figure S2 .
Analysis of the sodium ion's mobility and its coordination state reveals a high level of stability for the ion when bound to the receptor's inactive conformation. The dominant charge-charge interaction with Asp52 2.50 is clearly maintained along the simulation runs in the different MD trajectories, while the side chain oxygen atoms of Ser91 3.39 and Asn280 7.45 alternate direct interactions with the ion (Figure 2 ). More precisely, the ion fluctuates between a coordination state as seen in the crystal structure, which we will refer to as position c1, and a second state that we will refer to as position c2. This fluctuation involves an exchange between the sodium ion and the water molecule W52, initially linked to the OD1 of Asn280 7.45 , as shown in Figure 2A by the overlay of the electron density of the crystal structure with the volumetric density map calculated from the MD simulations. In position c2, the ion is still coordinated by Asp52 2.50 (OD1), while it is the OD1 of Asn280 7.45 (occasionally replaced by a new water molecule) that participates in the first coordination shell, which is completed with three other water molecules. The radial distribution function indicates the average sodium-oxygen distance is 2.4 Å, with the first coordination shell predominantly formed by 4 or 5 oxygen atoms (see supplemental Figure S2 ), in agreement with the geometric analysis of sodium ion binding sites found in the Protein Data Bank (PDB). 49 The consistent observation of these two dominant coordination modes suggests a possibility of fast exchange between the sodium ion and the water molecule, supported by the significantly shorter distance (2.2 Å) observed in the crystal structure for the Na + -O(W52) pair. Interestingly, this fast exchange occurs regardless of the presence of the antagonist ZM-241,385 in the orthosteric binding site (Table S1 ). In the setup MDS1b, we evaluated the effects of a physiological saline concentration in the simulations, and observed no difference in results (see supplemental Figure S2 and Table S1 ). Moreover, none of the sodium ions from the extracellular solvent could cross the narrow channel into the allosteric pocket during 100 ns simulations, suggesting that exchange of sodium ions in A 2A AR may occur on a longer time scale.
To investigate a possible effect of the sodium ion on the stability of the inactive conformation of the receptor, the MD simulations described above (MDS1 and MDS2) were compared with the corresponding simulations of the inactive A 2A AR in the absence of the ion (MDS3 and MDS4). The most pronounced difference in local conformational dynamics was located in the region of the sodium ion: the highly conserved residue Trp246 6.48 in the second sphere of solvation experienced a rotameric transition from theinitial g+ rotamer to the trans (t) conformation, observed in two out of three independent simulations of the apo receptor without sodium ion (MDS4, see Figure 3 ).
This rotameric change appears connected to a rotation of residue Asn280 7.45 from the initial g-rotamer to either trans or g+ ( Figure 3A and C) . In contrast, rotamer changes in Tpr246 6.48 and to a lesser extent Asn280 7. 45 were not observed when the sodium ion was bound to the allosteric site (MDS2), suggesting that the sodium ion contributes to a stabilization of these two residues ( Figure 3A and B) . Similarly, the furyl moiety of the antagonist ZM-241,385 stabilized the g+ rotamer of Trp246 6.48 through Van der Waals interactions (simulations MDS1 and MDS3). Consequently, no movements in this microenvironment occured with ZM-241,385 bound, regardless of the presence of the sodium ion.
The sodium ion binding site in the A 2A AR active-like conformation
Analysis of the agonist-bound structures of A 2A AR 18, 19 indicates that the activation-related changes in helix VII partially collapse the sodium ion pocket, making it incompatible with ion binding. 22 In order to further evaluate this effect, the sodium ion-water cluster was simulated in the context of the active-like conformation of A 2A AR with agonists UK-432,097 (MDS5) or NECA (MDS6), or without any agonist (MDS7, see Table 1 ). The simulations show that in the active-like state the receptor cannot bind the sodium ion, as evidenced by two alternative events that occur in the early stages of production runs. In the first event, (observed in 1 out of 3 replicas in MDS5, in 2 out of 3 replicas in MDS6, and in all 3 replicas in MDS7) the ion escaped from the proposed binding site. In the alternative event, observed in the remaining simulations, the ion remained in the allosteric binding site, but a conformational change of helix VII occurred, resembling the inactive-like conformation of helix VII observed in all antagonist-bound A 2A AR structures.
In particular, the region between His278 7.43 and Asn284 7.49 undergoes an outward movement driving helix VII apart from helix III and expanding the pocket cavity (Figure 4 ).
In the MDS5 and MDS6 simulations, this rearrangement was also accompanied by a loss of contact between His278 7.43 and the O2' of the ribose moiety of the agonist, suggesting that sodium ion binding destabilizes activation-related movements and agonist binding. Note that all conformational events described here occurred within the first 5-10 ns of the simulation, justifying that a total simulation time of 40 ns was sufficient to properly sample the sodium binding site in the active-like system. These findings indicate that the binding of sodium ions and agonists each require a different conformational state of the receptor and, therefore, are mutually exclusive. 
Amiloride and HMA as A 2A AR allosteric modulators
Amiloride and its derivatives are known to be nonspecific GPCR modulators. 50 A binding mode of amiloride and its bulkier analog HMA to the A 2A AR was determined by flexible side chain docking where the charged guanidinium group of amiloride interacted with Asp52 2.50 . 22 An additional hydrogen bond was also predicted between amiloride and the Trp246 6.48 side chain (see Figure 5A ), which is shifted ~1.5 Å towards the orthosteric pocket as a result of induced fit. This tight binding of amilorides is clearly not compatible with the collapsed allosteric pocket observed in the active-like conformation of the A 2A AR, in an even more pronounced way than in the case of sodium ions. Therefore, we explored this docking hypothesis with a series of MD simulations of the inactive A 2A AR in the presence of different orthosteric antagonists, i.e. the ternary complexes A 2A AR-ZM-241,385-amiloride (MDS8) and A 2A AR-caffeine-amiloride (MDS9). The effect of amiloride on the binding of antagonists turned out to be complex and varied between the different antagonist chemotypes tested. Figure 5D was observed in the presence of both amilorides. This effect is likely due to the influence of the side chain of Trp246 6.48 , which is the only residue that interacts with ZM-241,385 and amilorides simultaneously (in particular with the 5'-azepane substituent of HMA, see Figure 5C ), leading to the hypothesis that this highly conserved residue acts as an important link between the two sites. Consequently, binding of antagonists that do not directly interact with Trp246 6.48 , for example, caffeine, 14 should be less affected by the presence of amiloride in the allosteric site ( Figure 5B ). Indeed, we found no statistically significant difference for the mobility of caffeine as a function of the presence of amilorides ( Figure 5D ). Due to the high mobility of caffeine, which is small in size, has few receptor contacts, and displays low affinity, the simulation time in this particular system was limited to 40 ns time scale. 
Biochemical studies
Radioligand binding experiments were performed to examine the effects of sodium ions and amiloride derivatives on antagonist, [ 3 H]ZM-241,385, and agonist, [ 3 H]NECA, binding to the A 2A AR. In order to experimentally assess the dependence of ligand binding on the presence of a sodium ion in the allosteric site, we performed equilibrium displacement studies with increasing concentrations of NaCl ( Figure 6A) . These experiments show a full displacement of [ 3 H]NECA by sodium ions, with an IC 50 value of 49 ± 7 mM (Table S2 and Figure 6A ). In contrast, there is an enhancement of antagonist [ 3 H]ZM-241,385 binding, especially at higher sodium ion concentrations. All these results correlate with the MD conclusions that the sodium ion selectively stabilizes the antagonist-bound receptor state. Figure   S3 ). Interestingly, this reduction in agonist binding was due to an increase of the K D value while the radioligand's B max value remained at a control level, within experimental error.
Saturation binding experiments performed with [ 3 H]NECA also show that the presence of NaCl significantly reduces [ 3 H]NECA binding to the A 2A AR (Table 2 and
This profile of pharmacological parameters usually implies a competitive interaction between the two ligands. However, in this case the binding sites of the two ligands are not overlapping, therefore the observed "mutually exclusive binding" suggests that the sodium ion-bound conformation of A 2A AR is not compatible with agonist binding, and viceversa. In contrast, no significant effect of sodium ions was observed on the binding of the antagonist radioligand [ 3 H]ZM-241,385 to the A 2A AR ( Table 2) .
We also characterized the influence of amiloride and HMA on radioligand binding to the A 2A AR. The two compounds inhibited the binding of both agonist and antagonist radioligands in displacement assays, albeit with different potencies ( Figure 6B and 6C and Table S2 ). HMA proved to be more active than amiloride in both cases, and displayed the highest potency (2.4 µM) with the agonist [ 3 H]NECA as the radiolabel. Radioligand saturation experiments were performed in the presence of the amiloride analogs, revealing distinct differences between the two radioligands ( Table 2 and Figure S3 ). The on NECA's B max value, whereas all K D values were significantly increased, which we attribute to the mechanism of "mutually exclusive binding" discussed above for the case of agonist and sodium ion binding. NaCl (A), amiloride (B), and HMA (C) . Representative graphs from one experiment performed in duplicate on hA 2A ARs transiently expressed in HEK293T cell membranes. Associated IC 50 values listed in Table S2 .
Biophysical studies
The effects of sodium ions, orthosteric ligands and amiloride analogs on A 2A AR stability were analyzed with a series of thermal stability assays. 48 Increasing sodium ion concentrations induced a significant increase in the thermostability of the unliganded A 2A AR-BRIL complex, as shown in Figure 7A . A two-phase response was observed, with a modest increase in thermostability from 52 to 57 C at sodium ion concentrations below the physiological concentration of 150 mM, and a further more substantial increase to 65 C upon addition of higher concentrations up to 500 mM NaCl. 
Discussion
The 1.8 Å resolution structure of A 2A AR in complex with the antagonist ZM-241,385 revealed a highly conserved sodium ion binding site 22 and provided an excellent opportunity to examine the molecular mechanism of the allosteric modulation of sodium ions in this receptor. Our MD simulations suggest that the electron density assigned to the water molecule closest to sodium ion in the crystal structure (W52) could correspond to a second resonance position of the ion, which would involve direct interaction with another conserved residue, Asn280 7.45 (Figure 2 ). Although we could not find a clear evidence of such dynamic rearrangements in the A 2A AR crystal structure, this may reflect the "frozen" state of the sodium ion-water cluster at the low temperatures (~100K) used in cryocrystallography. While further crystallographic studies at room temperature may help to validate such subtle effects experimentally, 51 the thermal fluctuations explored by the MD simulations under physiological conditions are particularly suited to explore this phenomenon. 52 The potential dynamic nature of the sodium ion and water network in the allosteric pocket could partially explain why the ion was not observed previously in lower resolution GPCR structures. A closer look at this region in two recently published, antagonist-bound GPCR structures, i.e. carvedilol- 1 -adrenergic receptor 53 and FNA- opioid receptor, 54 reveals that they are indeed compatible with the presence of a sodium ion ( Figure S1 ). More recently, a similar configuration of the sodium ion/water network was also identified in other ligand complexes of the  1 -adrenergic receptor. 55 The communication between the highly conserved class A GPCR residues Asp 2.50 , Trp 6.48 , and to a lesser extent Asn 7.45 , had been suggested to occur through a cluster of water molecules. 24 The current MD results strongly support the preference of the sodium ion for the inactive conformation of this micro-environment, at least in the A 2A AR, suggesting that it contributes to its stabilization. The increased dynamic flexibility of Trp246 6.48 and Asn280 7.45 in the absence of the sodium ion ( Figure 3) is consistent with previous MD simulations of the A 2A AR, 37 and agrees well with similar MD simulations in the dopamine D 2 receptor with explicit consideration of a sodium ion. 27 The conformational flexibility of Trp 6.48 has been associated with the initial steps of the activation mechanism of GPCRs, 56, 57 probably by facilitating the higher order conformational changes observed in helix VI between inactive and active states.
Conversely, the presence of the sodium ion and coordinating water molecules in this pocket hampers an activation-related inward movement of helix VII towards helix III, 18, 19 as indicated by MD simulations. Instead, we observed an "inactivation" movement of helix VII in the agonist-bound conformation (Figure 4 ) that led to the loss of key agonistreceptor interactions, suggesting that the simultaneous binding of the allosteric ion and the orthosteric agonist to the same receptor molecule is unlikely. Such a structural mechanism explains the negative allosteric effect of sodium ions on agonist binding to the A 2A AR observed here ( Figure 6A and Table 2 ) and in earlier studies. 6, 22 In radioligand binding experiments performed with both agonist and antagonist radioligands, sodium ions differentially affected radioligand binding to the A 2A AR, providing further insights into its allosteric effect: they induced an increase in [ 3 H]ZM-241,385 binding, but abrogated [ 3 H]NECA binding in a concentration-dependent manner with an IC 50 value of approximately 50 mM ( Figure 6A ). This potency is in the same range of sodium ion concentrations that cause an increase in receptor thermostability (Figure 7) , indicating that sodium ion binding could mediate both effects. Moreover, this IC 50 corresponds to about one third of the extracellular physiological concentration of sodium ions. This suggests that about 75% of the A 2A ARs that are present in the body are in a sodium ion occupied state, provided that there is unrestricted access to the sodium binding site from the outside of the cell, as recently proposed for the dopamine D 2 receptor. 27 Thus, it is likely that sodium is significantly involved in modulating the physiological state of the A 2A AR and possibly other class A GPCRs. Figure   6A ), is in good agreement with an earlier study where the slight affinity increase of this radioligand at even higher sodium concentrations (1 M) 58 was due to a decrease in its dissociation rate. 6 The structural information and the computational results provided in this study suggest that binding of agonists and sodium ions can be considered as "mutually exclusive". 59 This mechanism is further supported by thermal stability assays, showing that antagonists ZM-241,385 and caffeine display additive stabilizing effects with sodium ions, whereas the agonist UK-432,097 stabilizes the receptor but shows no additive effect when any allosteric ligand is added ( Figure 7B ). Similar to sodium ions, the diuretic drug amiloride is an allosteric modulator of several GPCRs (Chapter 2), including such diverse subfamilies as adenosine, aminergic and gonadotropin-releasing hormone receptors. 6, [60] [61] [62] [63] [64] The present study in the human A 2A AR shows that both amiloride and its derivative HMA negatively modulate agonist binding (Table 2) , with HMA being more potent than amiloride in radioligand displacement studies ( Figure 6 ) as previously suggested by kinetic studies in the rat A 2A AR. 6 The saturation studies with [ 3 H]ZM-241,385 as the radioligand ( Table 2 ) also point to a noncompetitive interaction between amiloride and the antagonist binding site. Moreover, the additive increase in A 2A AR thermostability in the presence of both amiloride and the orthosteric antagonist caffeine ( Figure 7B ) suggests that both allosteric and orthosteric ligands can bind simultaneously. These findings are in concert with docking and MD simulations ( Figure 5 ), which suggest that amiloride and HMA bind in the allosteric sodium pocket, with the charged guanidinium group anchored by the carboxyl of Asp 2.50 . Although the proposed amiloride binding does not directly overlap with the orthosteric ligand binding site, our simulations indicate that amiloride derivatives can impact orthosteric ligand binding indirectly, primarily via modulation of Trp246 6.48 conformation. This explains a more pronounced negative allosteric effect of HMA, which has extensive steric interactions with the Trp246 6.48 side chain. Overall, the distinct allosteric effects of amilorides are probably the result of a delicate balance between an improved stability of the inactive conformation and an indirect (noncompetitive) interference with the orthosteric site for antagonists.
Interestingly, saturation binding experiments (
In summary, a combination of biochemical and thermal stability data with MD simulations, based on both inactive and the active-like crystal structures of the A 2A AR, provided valuable mechanistic insights into the role of the allosteric sodium ion in the conformational equilibrium of the receptor. Our findings suggest that the binding of either the sodium ion or amilorides to the allosteric pocket selectively stabilizes the inactive conformation of the receptor, and this allosteric effect is responsible for the observed reduction in orthosteric agonist binding. Comprehensive experimental and theoretical analyses of A 2A AR in simultaneous complex with both allosteric modulators and orthosteric ligands also explain, on a molecular basis, the distinct interaction profiles observed between allosteric amiloride derivatives and different orthosteric antagonists.
These observations pave the way for better understanding of GPCR allosteric control, which may be used in the design of novel allosteric modulators to more precisely tune receptor function.
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